Department of Oncology and Hemato-Oncology, Division of Early Drug Development, European Institute of Oncology, IRCCS and University of Milano, Milan, Italy.
Gynaecology Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.
Ann Oncol. 2020 Oct;31(10):1320-1335. doi: 10.1016/j.annonc.2020.07.010. Epub 2020 Jul 31.
We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic.
我们成立了一个国际联盟，旨在审查和讨论相关的临床证据，以制定与严重急性呼吸系统综合征冠状病毒 2 相关疾病（COVID-19）大流行期间癌症管理相关的专家共识声明。指导委员会编写了 10 个工作包，涉及从诊断到手术的重大临床问题。在由欧洲肿瘤内科学会牵头的一场有 62 位全球专家和一位患者代表参加的虚拟共识会议上，对这些声明进行了讨论、修订和投票。当无法达成共识时，专家组会修改声明，直到达成共识。总的来说，专家组就 28 条共识声明达成一致，这些声明可用于克服从诊断到治疗计划和 COVID-19 大流行期间治疗等许多不确定的临床和技术领域。
